Pharmacology and Pharmaceutical Sciences articles for Germany

Time frame: 1 June 2025 - 30 May 2026
Count: 120

Article ‘Count’ for Pharmacology and Pharmaceutical Sciences.

Journal Count Share
5 3.31
Cosurfactant-Induced Disorder in Polymersome Membrane Enhances Diffusion of Cargo Molecules 1.00
Natural Compound-Driven Nano-Self-Assembly for Multimechanistic Transdermal Antiobesity Therapy 0.42
Assembling Lipid Membrane Scaffolds on Microgel-Based Artificial Cells through Vesicle Fusion onto the Hydrogel Network 0.22
Enzyme-Loaded Microcapsules as Intracellular Organelles for the Degradation of Nanoplastics by Cells 1.00
Maintaining Shell Disorder with Kinked or Branched Ligands Stabilizes Apolar Nanoparticles 0.67
1 1.00
Interaction Mechanisms Between Antibiotics and Calcium Phosphate Cements as Pharmacologically Active Bone Graft Substitutes 1.00
2 0.20
Intrinsic Photoactive Star ZnPc–Poly(glutamate) Nanoplatforms for Multimodal Glioblastoma Therapy and Brain-Targeted Delivery 0.07
Bioengineered Violet Phosphorus Hybrid Nanoassembly for Pathogen-Specific Eradication of Multidrug-Resistant Bacteria 0.13
2 1.06
Unfolding and Degradation of Micellar Immunodrug Carriers Derived From End Group Modified Aliphatic Poly(Carbonate)s with Acid‐Responsive Ketal Side Groups 1.00
Activatable Enzymatic Nanoplatform Incorporated into Microneedle Patch for Relieving Tumor Hypoxia Augmented Photodynamic Therapy 0.06
5 3.29
POx-Lipids as an Alternative to PEG-Lipids? Multimethod Assessment of Chemistry and Structure 1.00
Advanced Quality and Comparability Assessment of mRNA-Loaded Lipid Nanoparticles: Absolute Size Distribution Profiles and Structure from AF4-Coupled Light and X-ray Scattering Measurements 0.95
Development of a Liposome-Based Serological Assay for SARS-CoV-2 Variants with Special Emphasis on Coupling Chemistries Required to Maintain Protein Antigenicity 1.00
Large Language Model-Empowered Compound Collision Cross-Section Prediction 0.14
Active Learning Improves Ionization Efficiency Predictions and Quantification in Nontargeted LC/HRMS 0.20
20 15.36
A Revised Model for Muscarine Biosynthesis Involving Lysine Trimethylation 1.00
Polyfluoroalkyl-Tagged Cell-Penetrating Peptide-Additives Enhance Intracellular Protein Delivery via Sustained Monomeric Lipid Interaction 1.00
A General Group Testing Strategy for Discovering Chemical Cooperativity 1.00
Targeting the Membrane‐Embedded Rhomboid Protease GlpG: A Multimodal Strategy for Inhibitor Discovery and Mechanistic Insight 0.77
Versatile and Selective Biomolecule Pulldown with Combinatorial DNA-Crosslinked Polymers 1.00
Pseudotetraivprolides from Pseudomonas entomophila Provide Insights into the Biosynthesis of Detoxin/Rimosamide-Like Anti-Antibiotics 1.00
Design, Synthesis, and Structural Evolution of Pseudo‐Natural Product IDO1 Inhibitors and Degraders 0.85
Heteromultivalent Nanogels as Highly Potent Inhibitors of Pseudomonas Aeruginosa 0.83
Discovery and Total Synthesis of Crossiguanipyrazines with Potent Activity Against Mycobacterium tuberculosis 0.74
Modular Access to sp3-Rich Bicyclo[1.1.1]pentane Bioisosteres via Energy-Transfer-Mediated Carbene Insertion 0.13
Identification of a Proteolysis-Targeting-Chimera that Addresses Activated Checkpoint Kinase-1 Reveals its Non-Catalytic Functions in Tumor Cells 0.75
Difluorinative Cyclopropene Rearrangement by I(I)/I(III) Catalysis: Regio- and Stereoselective Synthesis of Allyl Difluorides 1.00
High-Throughput Synthesis and Screening of a Cyanimide Library Identifies Selective Inhibitors of ISG15-Specific Protease mUSP18 0.33
Light‐Gated Amine Exchange in Diarylethene‐Crosslinked Microgels 0.94
Intracellular Delivery of Native Proteins by BioReversible Arginine Modification (BioRAM) on Amino Groups 1.00
Mitigating Molecular Aggregation in Drug Discovery With Predictive Insights From Explainable AI 0.40
Native Mass Spectrometry Facilitates Hit Validation in DNA‐Encoded Library Technology 0.42
Small Molecule-Induced Alterations of Protein Polyubiquitination Revealed by Mass-Spectrometric Ubiquitome Analysis 1.00
Two‐Step Crystal Dissolution: A Molecular Mechanism to Rationalize Empiric Models of Drug Release from API Formulations for Oral Administration 1.00
Electron‐Deficient Alkyne Lipids Enable Efficient Synthesis of Comparable Polymer Lipids via Copper‐Free Azide‐Alkyne Cycloaddition 0.19
1 0.11
Upadacitinib vs adalimumab in patients with rheumatoid arthritis and a prior inadequate response or intolerance to a tumour necrosis factor inhibitor: 12-week results from the randomised, double-blind, SELECT-SWITCH study 0.11
1 1.00
Pioglitazone attenuates complement-mediated microglial synaptic engulfment in an Alzheimer’s disease model 1.00
1 0.06
Glucose-dependent insulinotropic polypeptide receptor signaling in oligodendrocytes increases the weight-loss action of GLP-1R agonism 0.06
1 0.17
Metabolite-induced DNA damage drives stochastic stem cell loss and clonal hematopoiesis 0.17
1 1.00
Click chemistry enables rapid development of potent sEH PROTACs using a direct-to-biology approach 1.00
4 2.18
Scaling up mechanochemical reactions: linking crystalline phase evolution studied via in situ PXRD with kinetics from MCR-ALS 0.33
Promoting organic nucleation of diclofenac: hydrophobic interfacial interactions drive self-assembly 0.72
Maleic anhydride derived diphosphines: adaptable chelators for receptor-targeted 99mTc, 64Cu and 188Re radiotracers 0.13
Navigating chemical space: multi-level Bayesian optimization with hierarchical coarse-graining 1.00
1 0.02
Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP). 0.02
1 0.67
Sources and geographic differences in air releases of benzene in the United States 0.67
2 0.25
Heart failure with reduced ejection fraction in Sweden: patient adherence and persistence to quadruple pharmacotherapy prescription 0.09
Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis 0.16
2 0.36
Rational Design of Enzyme-Responsive Fluorescent Organoruthenium Prodrug for Real-Time Tracking of Cargo Release and Cytotoxicity 0.25
Temperature-Induced Polymorphism of LiSc(SO4)2·2H2O Allows the Control of the Yield of Scandium during Precipitation from Diluted Aqueous Solutions 0.11
1 0.11
Oral contraceptive use and risk of melanoma in a large cohort of Dutch nurses 0.11
1 0.12
GH001 vs Placebo in Patients With Treatment-Resistant Depression 0.12
6 2.45
Co-solute Effects Reveal the Nature of Weak Forces Governing GLP-1 Oligomers Stability 0.13
The stress-activated kinase p38 mediates non-canonical activation of Src and tyrosine phosphorylation of the adapter protein TAB1 0.06
The divergent roles of tryptophans W354 and W217 in OCT1 transport: similar localization, distinct functions 1.00
Phylogenetic and structural analyses reveal Cdc2-like kinases (CLKs) as ancient regulators of thermosensitive splicing 0.20
The organic cation transporters 1 and 2 mediate ethanolamine cellular efflux and control systemic phosphatidylethanolamine level 0.17
Ascorbate mitigates oxidative stress and hemin cytotoxicity in heme oxygenase-1 deficiency 0.90
1 0.17
The NUDIX hydrolase NUDT5 regulates thiopurine metabolism and cytotoxicity 0.17
1 0.42
Glucagon controls obesity-specific energy expenditure via persistent cAMP/PKA signaling 0.42
1 0.33
Translational Modeling of BTZ-043 to Predict Phase 2A Efficacy and Evaluate Drug-Drug Interactions With Bedaquiline, Pretomanid, and Linezolid in Murine Models 0.33
14 7.68
Yield Prediction of Organic Reactions in Biased Data Sets via Positive-Unlabeled Learning 1.00
Structural Mass-Spectrometric Description of Immune Complexes in Vaccine-Induced Immune Thrombocytopenia and Thrombosis 0.22
Bimetallics Spanned by Linear All-Inorganic Ligands: The Longest Inorganic, All-sp Chains 1.00
Supramolecular Polymorphism of an Ir(III) Complex: Kinetic/Thermodynamic Control and Mechano-Responsiveness 0.29
The Effect of Nonsolvent Post-Processing Induced Structural and Morphological Changes on the Optoelectronic Properties of CsPbBr3 Nanocrystals 0.10
Augmenting Large Language Models for Automated Discovery of F-Element Extractants 0.10
In Situ Transformable Photothermal Targeting Chimeras for Spatiotemporally Controllable Protein Degradation and Combination Immunotherapy for Cancer 0.08
Receptor-Mediated Shuttling of a D-Amino Acid Peptide Achieves High Nanomolar Cytosolic Concentrations 1.00
Accurately Predicting Solubility Curves via a Thermodynamic Cycle, Machine Learning, and Solvent Ensembles 0.20
Luminescent Perhalofluoro Trityl Radicals 1.00
Bayesian Optimization for Multicomponent Supramolecular Systems 0.04
Highly Branched Sulfated Glycopolymers as Mucin Mimetics 0.89
A Chemo-Enzymatic Platform for Furanolide Synthesis and Functional Exploration 1.00
Isomerization of Poly(ethylene glycol): A Strategy for the Evasion of Anti-PEG Antibody Recognition 0.77
1 0.03
Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy 0.03
1 0.06
A predictive model for life-threatening fluoropyrimidine toxicity based on DPYD sequencing in colorectal cancer 0.06
2 0.55
Effect of Copolymer Chemistry on the Humidity- and Temperature-Dependent Mechanical Properties and Structure of Polyelectrolyte Complexes 0.43
Boron-Rich Soft Hydrogels Based on the Coassembly of Cationic A-B-A Triblock Copolymers with Closo-Dodecaborate 0.13
1 0.01
Expanding the druggable zinc-finger proteome defines properties of drug-induced degradation 0.01
2 1.14
Multiomics analysis identifies VPA-induced changes in neural progenitor cells, ventricular-like regions, and cellular microenvironment in dorsal forebrain organoids 1.00
A five-year risk prediction model of cardiovascular disease in individuals with bipolar disorder: a nationwide register study from Sweden 0.14
2 0.41
Polymer Blend Controls Nanoparticles’ Surface Charge for Improved Mucus Penetration and Epithelial Cell Adhesion 0.14
Dual-Targeting Nanoplatform to Regulate Metabolic Disorders: From Obesity to Obesity-Related Metabolic Dysfunction-Associated Steatotic Liver Disease 0.27
2 0.67
GLP-1R–GIPR–PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice 0.47
Inhibitors supercharge kinase turnover through native proteolytic circuits 0.20
3 1.63
Charged molecular glue discovery enabled by targeted degron display 0.20
Enzymatic epimerization of monoterpene indole alkaloids in kratom 0.67
Molecular recording of cellular protein kinase activity with chemical labeling 0.77
2 1.72
Monovalent pseudo-natural products supercharge degradation of IDO1 by its native E3 KLHDC3 0.72
On-DNA C–H functionalization of electron-rich arenes for DNA-encoded libraries 1.00
11 7.54
Targeted degradation of USP7 in solid cancer cells reveals distinct effects of deubiquitinase degraders and inhibitors 1.00
Structural optimization of drug molecules with incrementally trained language models 1.00
GLP-1R associates with VAPB and SPHKAP at ERMCSs to regulate β-cell mitochondrial remodelling and function 0.25
Barcode-free hit discovery from massive libraries enabled by automated small molecule structure annotation 0.33
Extending quantum-mechanical benchmark accuracy to biological ligand-pocket interactions 0.07
The π-trap approach for obtaining crystal structure data of inherently amorphous cluster compounds 1.00
Unbiased mapping of cereblon neosubstrate landscape by high-throughput proteomics 0.48
Simulations and active learning enable efficient identification of an experimentally-validated broad coronavirus inhibitor 0.81
Resolving the structural basis of therapeutic antibody function in cancer immunotherapy with RESI 0.60
A self-regulating shuttle for autonomous seek and destroy of microplastics from wastewater 1.00
Boron-chalcogen heterocycles and linear tetraboranes from a cyclic tetra(amino)tetraborane 1.00
1 0.06
Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals 0.06
1 0.40
C(sp3)–F Bond Functionalization of Isoflurane with Complex Phenols for the Synthesis of CF2-Based (Deuterated) Aryl Ethers 0.40
1 0.08
The benefits and risks of maternal RSV vaccination on mortality in South Africa: A modeling study 0.08
5 2.24
A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit 0.27
Opioid-specific brain connectivity dynamics distinguish analgesia from secondary effects: Studies in male mice 0.17
Lipoprotein diffusion in dense yolk plasma is governed by softness, hydrodynamics, and caging: Insights from MHz-XPCS 0.83
Manifold-constrained nucleus-level denoising diffusion model for structure-based drug design 0.11
Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants 0.86
1 0.07
Assessing Drug-mediated Inhibition of Liver Transporter Function with MRI: A First-in-Human Study. 0.07
1 0.09
Active learning framework leveraging transcriptomics identifies modulators of disease phenotypes 0.09
3 1.16
Universal progression of structure and dynamics in colloidal nanocrystal gels during salt-accelerated aging 0.06
Preclinical development of a well-defined semisynthetic glycoconjugate vaccine against Haemophilus influenzae type b 0.10
Single-molecule localization microscopy reveals the molecular organization of endogenous membrane receptors 1.00
1 0.02
Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma models 0.02
1 0.50
Adherence to legislation and recommendations to publicly post protocols and results of post-authorisation studies registered with European Medicines Agency: cross sectional study 0.50
1 0.94
Molecular requirements for PLK1 activation by T-loop phosphorylation 0.94
1 0.09
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials 0.09
1 0.03
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study 0.03

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.